Replies to post #245275 on Biotech Values

[mouton29]

<<What EOLS showed was not the duration of none-or-mild status per se, but rather the time to return to baseline among the subset of patients who ever attained none-or-mild status.>>

So that if there were one patient who acheived non or mild out of 50, and she took 7 months to return to baseline, the EOLS metric would say, 7 months for patients who acheive non or mild to return to baseline. Wowza.